Conflicts of interest
This study was funded by Galderma. R.K., L.S., W.W., J.R., R.-M.S., E.V., L.E.R. received funding support from Galderma to conduct this study. N.K., V.S., H.V. are employees of Galderma.

Read the full text

About

PDF

Tools

Share a link

Email
Wechat
Bluesky

Summary

Background Methyl aminolaevulinate–photodynamic therapy (MAL-PDT) is an effective treatment in facial/scalp actinic keratosis (AK).

Objectives The aims of this study were to compare efficacy, safety, cosmetic outcome and patient preference of MAL-PDT vs. cryotherapy in patients with AK at other locations.

Methods A multicentre, controlled, randomized, open, intraindividual, right–left comparison was performed. Patients with nonhyperkeratotic AK were treated once with MAL-PDT and cryotherapy on either side of the body. At week 12, lesions showing noncomplete response were retreated. The primary efficacy variable was the lesion response at week 24. Investigator’s assessment of cosmetic outcome, patient’s preference in terms of cosmetic outcome and a patient preference questionnaire were also analysed at week 24.

Results In total, of 121 patients with 1343 lesions (98% located on the extremities and the remainder on the trunk and neck) were included. Both treatments provided a high mean percentage reduction in lesion count at week 24 with significantly higher efficacy for cryotherapy: 78% for MAL-PDT and 88% for cryotherapy (P = 0·002, per protocol population). Investigator’s assessment of cosmetic outcome was significantly better for MAL-PDT than cryotherapy (P < 0·001), 79% of lesions having an excellent cosmetic outcome with MAL-PDT vs. 56% with cryotherapy at week 24. The cosmetic outcome achieved by MAL-PDT compared with cryotherapy was also preferred by patients (50% vs. 22%, respectively, P < 0·001), and 59% of patients would prefer to have any new lesions treated with MAL-PDT compared with 25% with cryotherapy (P < 0·001). Both treatment regimens were safe and well tolerated.

Conclusions MAL-PDT showed inferior efficacy for treatment of non-face/scalp AK compared with cryotherapy. However, both treatments showed high efficacy, and MAL-PDT conveyed the advantages of better cosmesis and higher patient preference.

References

1 Halpern AC, Hanson LJ. Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians. Int J Dermatol 2004; 43: 638–42.
10.1111/j.1365-4632.2004.02124.x
PubMed Web of Science® Google Scholar
2 Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; i: 795–7.
10.1016/S0140-6736(88)91658-3
Google Scholar
3 Hurwitz RM, Monger LE. Solar keratosis: an evolving squamous cell carcinoma. Benign or malignant? Dermatol Surg 1995; 21: 184.
10.1111/j.1524-4725.1995.tb00141.x
PubMed Web of Science® Google Scholar
4 Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42: 23–4.
10.1067/mjd.2000.103339
CAS PubMed Web of Science® Google Scholar
5 Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: S4–7.
10.1067/mjd.2000.103342
CAS PubMed Web of Science® Google Scholar
6 Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol 2000; 42: S25–8.
10.1067/mjd.2000.103338
CAS PubMed Web of Science® Google Scholar
7 Lubritz RR, Smolewski PA-C. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol 1982; 7: 631–2.
10.1016/S0190-9622(82)70143-4
PubMed Web of Science® Google Scholar
8 Zouboulis CC. Cryosurgery in dermatology. Eur J Dermatol 1998; 8: 466–74.
CAS PubMed Web of Science® Google Scholar
9 Balkrishnan R, Cayce KA, Kulkarni AS et al. Predictors of treatment choices and associated outcomes in actinic keratoses: results from a national physician survey study. J Dermatol Treat 2006; 17: 162–6.
10.1080/09546630600765081
PubMed Web of Science® Google Scholar
10 Peng Q, Soler AM, Warloe T et al. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B 2001; 62: 140–5.
10.1016/S1011-1344(01)00173-7
CAS PubMed Web of Science® Google Scholar
11 Siddiqui AA, Perry MC, Scott JL. Topical methyl aminolevulinate. Am J Clin Dermatol 2004; 5: 127–37.
10.2165/00128071-200405020-00006
PubMed Web of Science® Google Scholar
12 Angell-Petersen E, Sorensen R, Warloe T et al. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 2006; 126: 265–71.
10.1038/sj.jid.5700048
CAS PubMed Web of Science® Google Scholar
13 Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001; 145: 467–71.
10.1111/j.1365-2133.2001.04407.x
CAS PubMed Web of Science® Google Scholar
14 Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002; 47: 258–62.
10.1067/mjd.2002.119649
CAS PubMed Web of Science® Google Scholar
15 Freeman M, Vinciullo C, Francis D, Spelman L. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix^®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003; 14: 99–106.
10.1080/09546630310012118
CAS PubMed Google Scholar
16 Pariser DM, Lowe NJ, Stewart DM, Jarratt MT. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003; 48: 227–32.
10.1067/mjd.2003.49
PubMed Web of Science® Google Scholar
17 Morton C, Campbell S, Gupta G, Keohane S. Intra-individual, right–left comparison of topical methyl aminolaevulinate–photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006; 155: 1029–36.
10.1111/j.1365-2133.2006.07470.x
CAS PubMed Web of Science® Google Scholar
18 Braathen LR, Szeimies RM, Basset-Seguin N et al. Guidelines on the use of photodynamic therapy for non-melanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007; 56: 125–43.
10.1016/j.jaad.2006.06.006
PubMed Web of Science® Google Scholar
19 Tarstedt M, Rosdahl I, Berne B et al. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol (Stockh) 2005; 85: 424–8.
10.1080/00015550510032887
CAS PubMed Web of Science® Google Scholar
20 Kurwa HA, Yong-Gee SA, Seed PT et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999; 41: 414–18.
10.1016/S0190-9622(99)70114-3
CAS PubMed Web of Science® Google Scholar
21 Szeimies RM, Karrer S, Sauerwald A, Landthaler M. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology 1996; 192: 246–51.
10.1159/000246376
PubMed Web of Science® Google Scholar
22 Lebwohl M, Dinehart S, Whiting D et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol 2004; 50: 714–21.
10.1016/j.jaad.2003.12.010
PubMed Web of Science® Google Scholar

Citing Literature

Volume158, Issue5

May 2008

Pages 994-999

Multicentre intraindividual randomized trial of topical methyl aminolaevulinate–photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities

Summary

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Multicentre intraindividual randomized trial of topical methyl aminolaevulinate–photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities

Summary

References

Citing Literature

References

Related

Information